Metabolic Profiling of Adiponectin Levels in Adults: Mendelian Randomization Analysis.

Maria Carolina Borges1, Aluísio J D Barros2, Diana L Santos Ferreira2

  • 1From the Post-Graduate Program in Epidemiology, Federal University of Pelotas, Brazil (M.C.B., A.J.D.B., B.L.H., D.F.F., I.O.O.); MRC Integrative Epidemiology Unit (M.C.B., D.L.S.F., T.R.G., D.A.L.) and Population Health Sciences, Bristol Medical School (M.C.B., D.L.S.F., T.R.G., Y.B.-S., D.A.L.), University of Bristol, United Kingdom; Farr Institute of Health Informatics (J.P.C., A.D.H.), Department of Epidemiology and Public Health (M. Kivimaki, M. Kumari), Department of Women's Cancer, Institute for Women's Health, Faculty of Population Health Sciences (U.M., A.G.-M., E.F.), and Institute of Cardiovascular Science (A.D.H.), University College London, United Kingdom; Institute for Social and Economic Research, University of Essex, United Kingdom (M. Kumari); and Department of Physiology and Pharmacology, Institute of Biology, Federal University of Pelotas, Brazil (I.O.O.). m.c.borges@bristol.ac.uk.

Summary

Higher blood adiponectin levels correlate with a healthier metabolic profile in observational studies, but causal links are not supported by genetic analysis. Adiponectin appears to be an epiphenomenon in metabolic disease.